Here's how embracing a comprehensive, patient-centered approach and staying informed about emerging treatments can help mental health professionals make a difference in the lives of patients with TRD.
Cannabis use disorder and nonadherence: How can we best educate patients?
How to help individuals caught in human trafficking: person-centered, culturally humble, trauma-informed care.
How do we find the right treatments for our patients with schizophrenia at every step of their journey?
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
In a shock-prone world, city-level thinking is a new approach to optimizing the brain health and brain skills of citizens.
As the COP-26 (Conference of the Parties) gets ready to convene to discuss climate change, it is crucial for them to consider brain science.
Faced with the trend toward shorter length of stay in inpatient psychiatric units, practitioners and patients in need of care face dramatic changes in treatment.
The president of the San Diego Psychiatric Society gives us a glimpse into the city for the upcoming 2022 Annual Psychiatric Times World CME Conference.
Experts share their best practices and tips.
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
Disruptions to cognitive control, as well as to emotional processes, are implicated in a wide range of psychiatric disorders.
Here's how medical practitioners and researchers can influence AI reasoning and influence in the future of AI development and deployment.
Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.
Online environments have revolutionized the lives of young SGM individuals, but also created unforeseen issues...
The impacts of this pandemic continue to ripple. All we can do is try our best to stay informed. That’s where we come in.
Individuals with schizophrenia have experienced an increase in psychiatric, medical, and treatment risks because of the COVID-19 pandemic.
"This pandemic represents an unprecedented time that requires a psychiatrist’s vigilance in identifying patients at risk for COVID-19–induced psychosis."
Regular THC use in adolescence is not a benign activity—it can have life-changing consequences. Here’s what you need to know.
Parenteral ketamine is commonly used to manage agitation that is deemed severe and obstructive to necessary medical evaluation and treatment. But what does this suggest about the relationship between medicine and society?
Brain Capital: a fresh approach to technologies and investing.
Elizabeth Lowenhaupt, MD, CCHP, shares her insights and experiences on correctional psychiatry and juvenile mental health as she looks toward the future of the field.
Psychopharmacology, while an essential tool, is only one of those tools.
Here’s everything you need to know to about how to integrate apps into your clinical practice.
During the pandemic, this psychiatrist is only able to connect to his beloved grandchild through FaceTime. He considers it a blessing.
Learn more about the company partnering with Janssen to bring high-quality, accessible, scaleable, and affordable therapeutic solutions.
Psychiatrists may wish to engage the primary care team to conduct a comprehensive case formulation that takes cultural factors into account.
Unity with the military helped a Northeastern Hospital during the COVID-19 pandemic.